A Double-Blind, Randomized, Active-Comparator (Metformin) Controlled, Clinical Trial to Study the Efficacy and Safety of the Strategy to Start Patients With Type 2 Diabetes Mellitus on Janumet™ Compared to Metformin

PHASE3UnknownINTERVENTIONAL

Enrollment

1,000

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2012

Conditions

Diabetes Type 2

Interventions

DRUG

Metformin 1500 mg daily

500 mg thrice daily

DRUG

Metformin + Janufer (Janumet)

Titration up to 1500/150 mg daily

Trial Locations (1)

RECRUITING

Clalit Health services center, Tel Aviv